The Next Big Thing ...
Health Care: Health Services
Spherix Inc. (SPEX: NASDAQ)
$0.76 -0.04 | -5.00%
05/24/12 - 03:54 PM ET
3.73K / 95.20K
Vol / Avg. Vol:0.76 / 0.80
Open / Prev. Close:0.73 - 0.80
Today's Range:0.67 - 5.86
52 Wk Range:-35.04%
Performance YTD:TheStreet Rating:
Portfolios with SPEX
- Portfolio NameUser Type
- ContributorDollar Store
- UserBENITRANS IA
- UserKleenex
- Usernedlogbear
- Userkaboom pennies
- UserJOHN BERENT Portfolio 1
- User88Diesels Portfolio 1
- Usermark anthony
- Userrobert1903 Portfolio 1
- Usercibucko Portfolio 1
Latest SPEX Headlines from TheStreet
- Biotech Sector Weekly Rewind 10.09.10 | 08:10 am
- Alvarion, Spherix: Volume Movers 10.07.10 | 10:10 am
- GT Solar, IncrediMail: Volume Movers 09.07.10 | 01:09 pm
- Biotech Stock Mailbag: Keryx Biopharmaceuticals 01.29.10 | 07:01 am
- Sprint, CombinatoRx: Early Volume Plays 11.16.09 | 09:11 am
- Spherix 2Q Loss Widens On Higher Costs 08.17.09 | 03:08 pm
- Thursday's Small-Cap Winners & Losers 10.26.06 | 03:10 pm
- Today's Small-Cap Winners and Losers 03.23.06 | 02:03 pm
- Spherix Surges Anew on Europe OK 12.15.05 | 01:12 pm
- Spherix's Toothy Smile 12.09.05 | 04:12 pm
Press Releases for SPEX
- New Studies Conducted By Spherix Support Use Of D-Tagatose To Reduce And Stabilize Atherosclerotic Plaques - PR Newswire 04.18.12 | 02:04 pm
- Reminder: Spherix To Hold Business Update Conference Call April 11 At 1:00 P.m. Eastern Time - PR Newswire 04.10.12 | 11:04 am
- Spherix To Present Newest Work On Lipoproteins And Atheromas At Pittcon, The World's Largest Annual Expo For Laboratory Science - PR Newswire 03.08.12 | 03:03 pm
- SPX-106T Arrests Development Of Atherosclerotic Plaques In Mouse Model Of Cardiovascular Disease - PR Newswire 03.07.12 | 09:03 am
- Spherix To Present At The LHA Life Sciences & Medical Technologies Virtual Conference On February 16 - PR Newswire 02.10.12 | 10:02 am
- Spherix Announces Closing Of Registered Direct Offering Of $1.15 Million In Common Stock And Warrants - PR Newswire 02.07.12 | 01:02 pm
- Spherix Announces Registered Direct Offering Of $1.15 Million - PR Newswire 02.02.12 | 02:02 pm
- Spherix Announces Successful Completion Of Important Toxicology Study Of SPX-106 - PR Newswire 01.11.12 | 09:01 am
- Spherix Issues Reminder Of Business Update Conference Call Set For Today At Noon Eastern Time - PR Newswire 11.16.11 | 10:11 am
- Spherix Announces Closing Of Private Placement Of $1.25 Million, Discusses Use Of Proceeds - PR Newswire 10.28.11 | 03:10 pm
Partner Headlines for SPEX
- UPDATE: SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease - Benzinga 03.07.12 | 09:03 am
- Spherix Announces Reverse Stock Split Effective May 6, 2011 (SPEX) - Benzinga 05.06.11 | 01:05 pm
- Spherix Incorporated Reports FY 2010 EPS ($0.43) (SPEX) - Benzinga 03.30.11 | 01:03 pm
- UPDATE 1-Spherix says diabetes drug effective, shares jump - Reuters 10.07.10 | 10:10 am
- Spherix Type 2 Diabetes Therapy Shows Strong Clinical Results - Fox Business 10.07.10 | 10:10 am
- Spherix Updates Development Pipeline - Analyst Blog - Zacks 06.24.10 | 04:06 pm
- Tagatose Development On-Track - Analyst Blog - Zacks 04.23.10 | 01:04 pm
